Transaction in Own Shares

Summary by AI BETAClose X

Melrose Industries PLC has announced the purchase of 24,800 ordinary shares between July 27th and July 30th, 2026, through Merrill Lynch International. The volume-weighted average price for these shares ranged from 473.97p to 477.22p, with individual share prices varying between 462.80p and 483.90p. These purchased shares will be held in treasury, bringing the total number of shares held in treasury to 65,377,797 and the number of shares in issue to 1,246,097,524.

Disclaimer*

Melrose Industries PLC
03 August 2026
 







3rd August 2026




Melrose Industries PLC

("Melrose" or the "Company")

Transaction in Own Shares

 






The Company announces today it has purchased the following number of its ordinary shares of £0.001 each through Merrill Lynch International ("MLI") in the period from 27ᵗʰ July 2026 to 30ᵗʰ July 2026.







Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (pence)

Highest price per share (p)

27 July 2026

XLON

473.9746

6,200

462.8000

479.7000

28 July 2026

XLON

476.6447

6,200

472.7000

480.2000

29 July 2026

XLON

477.2177

6,200

473.6000

481.5000

30 July 2026

XLON

475.9104

6,200

468.7000

483.9000













The Company intends to hold the purchased shares in treasury.







Following the above transaction, the Company has 65,377,797 ordinary shares in treasury and has 1,246,097,524 ordinary shares in issue (excluding treasury shares).













Individual Transactions

 



In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by the MLI on behalf of the Company as part of the buyback programme is attached to this announcement.


http://www.rns-pdf.londonstockexchange.com/rns/8240O_1-2026-7-31.pdf








For further information please contact:




Warren Fernandez                        Company Secretary



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100